REFRACTORY LUPUS NEPHRITIS
Clinical trials for REFRACTORY LUPUS NEPHRITIS explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY LUPUS NEPHRITIS trials appear
Sign up with your email to follow new studies for REFRACTORY LUPUS NEPHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cancer technique takes on autoimmune diseases: CAR t cells target lupus, scleroderma, and Sjogren's
Disease control Recruiting nowThis study tests a new treatment using a patient's own immune cells, modified to attack harmful cells in three severe autoimmune diseases: lupus kidney disease, scleroderma, and Sjogren's syndrome with lung complications. About 45 adults will receive a single infusion of CD19-BCM…
Matched conditions: REFRACTORY LUPUS NEPHRITIS
Phase: PHASE1, PHASE2 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Could a single infusion of supercharged immune cells tame three brutal autoimmune diseases?
Disease control Recruiting nowThis early-phase trial is testing a new treatment made from donated cord blood cells, engineered to target and destroy faulty immune cells. It is for people with severe lupus kidney disease, systemic sclerosis, or Sjogren's syndrome with lung complications. The main goal is to se…
Matched conditions: REFRACTORY LUPUS NEPHRITIS
Phase: PHASE1, PHASE2 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
15-Year safety check for experimental CAR t therapy begins
Knowledge-focused Recruiting nowThis study tracks 70 people who have already received an infusion of KYV-101, a CAR T cell therapy, for autoimmune diseases like lupus, multiple sclerosis, and rheumatoid arthritis. The goal is to watch for delayed side effects, new cancers, or other health problems over up to 15…
Matched conditions: REFRACTORY LUPUS NEPHRITIS
Sponsor: Kyverna Therapeutics • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC